homeostasis/metabolism
• total bilirubin levels in the plasma is increased 40-fold compared to in wild-type mice
• levels of bilirubin conjugated to glucoronide and unconjugated bile acids are increased compared to in wild-type mice
|
• total bile acid in the plasma is increased 4-fold compared to in wild-type mice
|
• mice excrete the entire dose of methotrexate (MTX) unlike wild-type mice that excrete only 40% of the dose
|
• urinary excretion of bilirubin is detected unlike in wild-type mice
|
• methotrexate (MTX) levels in the small intestine are decreased 16.6-fold compared to in wild-type mice
• liver accumulation of MTX and fexofenadine ([H3]FEX) is decreased compared to in wild-type mice
• MTX levels in the plasma, kidney, brain, and spleen are increased compared to in wild-type mice
• mice excrete the entire dose of MTX unlike wild-type mice that excrete only 20% of the dose
• 2% of the MTX dose ends up in the feces compared with 20% in wild-type mice
• upon rifampicin treatment, liver MTX and 7OH-MTX levels are reduced to a greater extent than in similarly treated wild-type mice
• plasma concentrations of [H3]FEX are increased compared to in wild-type mice
• however, intestinal absorption of MTX is normal
|
liver/biliary system
• biliary secretion is half that of wild-type mice
• however, total bile acid pool size is normal
|
renal/urinary system
• mice excrete the entire dose of methotrexate (MTX) unlike wild-type mice that excrete only 40% of the dose
|
• urinary excretion of bilirubin is detected unlike in wild-type mice
|
growth/size/body
• in male and female mice between 9 and 14 weeks of age
|